SMN1M-RT50
SMN1 Exon7/8 Screening Kit
Quantity: 50 Tests
£815.00
The geneMAP™ SMN1 Exon7/8 Deletion Screening Kit is a diagnostic tool designed for the rapid and cost-effective analysis of deletions in Exon 7 and Exon 8 of the SMN1 gene, which are indicative of Spinal Muscular Atrophy (SMA). Utilizing TaqMan probe-based CNV (Copy Number Variation) analysis and compatible with three-color real-time PCR instruments (FAM, VIC/HEX, and ROX), this CE-IVD certified kit facilitates accurate screening for one of the most common genetic causes of muscle weakness and atrophy.
- Rapid and Cost-Effective: Specifically designed for quick deletion analysis of the SMN1 gene, optimizing both time and expense.
- TaqMan Probe-Based CNV Analysis: Ensures accurate results through quantitative fluorescence real-time PCR and CNV analysis using the Comparative Ct Method.
- Compatibility: Works with FAM, VIC/HEX, and ROX three-color real-time PCR instruments, broadening its applicability.
- CE-IVD Certification: Meets European standards for in vitro diagnostic medical devices, guaranteeing reliability and quality.
- SMA Screening and Diagnosis: Essential for the detection of SMN1 exon deletions, providing critical information for diagnosing Spinal Muscular Atrophy.
- Genetic Counseling: Plays a significant role in carrier testing and genetic counseling, especially given the high carrier frequency of SMA in the population.
- Technology: Utilizes allele-specific quantitative fluorescence real-time PCR for Copy Number Variation (CNV) analysis based on the Comparative Ct Method.
- Target Analysis: Specifically designed for the analysis of deletions in Exon 7 and/or Exon 8 of the SMN1 gene.
- Compatibility: Suitable for use with real-time PCR instruments capable of detecting FAM, VIC/HEX, and ROX.
- Certification: Carries the CE-IVD mark, indicating its approved use within the European Union for in vitro diagnostics.
- Rapid and Cost-Effective: Specifically designed for quick deletion analysis of the SMN1 gene, optimizing both time and expense.
- TaqMan Probe-Based CNV Analysis: Ensures accurate results through quantitative fluorescence real-time PCR and CNV analysis using the Comparative Ct Method.
- Compatibility: Works with FAM, VIC/HEX, and ROX three-color real-time PCR instruments, broadening its applicability.
- CE-IVD Certification: Meets European standards for in vitro diagnostic medical devices, guaranteeing reliability and quality.
- SMA Screening and Diagnosis: Essential for the detection of SMN1 exon deletions, providing critical information for diagnosing Spinal Muscular Atrophy.
- Genetic Counseling: Plays a significant role in carrier testing and genetic counseling, especially given the high carrier frequency of SMA in the population.
- Technology: Utilizes allele-specific quantitative fluorescence real-time PCR for Copy Number Variation (CNV) analysis based on the Comparative Ct Method.
- Target Analysis: Specifically designed for the analysis of deletions in Exon 7 and/or Exon 8 of the SMN1 gene.
- Compatibility: Suitable for use with real-time PCR instruments capable of detecting FAM, VIC/HEX, and ROX.
- Certification: Carries the CE-IVD mark, indicating its approved use within the European Union for in vitro diagnostics.
Why Choose Clent
We strive to enable our customers to focus on the results of their work, rather than the tools they use. Need to speak with a member of our team? Get in touch today.
